Company intelligence / Profile preview

Revamp Medical

Netanya, Central District, Israelrevampmedical.com ↗

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Revamp Medical has developed the Doraya catheter, a device designed to improve diuretic efficacy and urine output in acute heart failure patients. Early results suggest improved clinical signs and symptoms such as edema, ascites, and dyspnea; reduced hospital stay length; and lower 30-day readmission rates. The company was founded in 2016 and has received EU Horizon 2020 SME Instrument funding.

Therapeutic areas: Cardiovascular
Modalities: DeviceCatheter-based device
Industry: Surgical Medical Devices

Partnerships

European Union’s Horizon 2020 SME Instrument program grant recipient

Beyond the preview

Go deeper on Revamp Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revamp Medical.

Explore the full profile